Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2
The closest safety dataset is the Increlex (mecasermin) clinical program , which followed 71 pediatric patients with severe primary IGFD on twice-daily SubQ rhIGF-1 for a mean of 3.9 years (some patients up to 11.5 years)
Promotes angiogenesis, helping build new blood vessels that improve oxygen and nutrient delivery where it's needed most
Prohibited by the World Anti-Doping Agency in competition Product Specifications Format: lyophilized peptide blend in vial (1:1 BPC-157 to TB-500 ratio
Headache Nausea and vomiting Diarrhea Dizziness Hypersensitivity reactions such as hasty, prickle, and struggling respire Chest pain Irregular heartbeat Shortness of breath Inflammation of the face, lips, tongue, or gullet Packaging Methycobal injection is available in different packaging depending on the manufacturer and country of origin
Fresh syringe, fresh needle, every single draw
US$ 20.80
US$ 22.77
US$ 28.14
US$ 24.84
US$ 26.95
